Evidence map›Paper›PMID 35058932›Full record

ArticleFrontiers in immunology2021

The Structure and Immune Regulatory Implications of the Ubiquitin-Like Tandem Domain Within an Avian 2'-5' Oligoadenylate Synthetase-Like Protein.

Justin D Shepard, Brendan T Freitas, Sergio E Rodriguez, Florine E M Scholte, Kailee Baker, Madelyn R Hutchison, Jaron E Longo, Holden C Miller, Brady M O'Boyle, Aarushi Tandon and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Functional Analysis of Oligoadenylate Synthetase in the Emu (Animals : an open access journal from MDPI · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Justin D ShepardDepartment of Infectious Diseases, University of Georgia, Athens, GA, United States.
Brendan T FreitasDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA, United States.
Sergio E RodriguezDivision of High Consequence Pathogens and Pathology, Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Florine E M ScholteDivision of High Consequence Pathogens and Pathology, Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Kailee BakerDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA, United States.
Madelyn R HutchisonDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA, United States.
Jaron E LongoDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA, United States.
Holden C MillerDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA, United States.
Brady M O'BoyleDepartment of Infectious Diseases, University of Georgia, Athens, GA, United States.
Aarushi TandonDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA, United States.
Peng ZhaoComplex Carbohydrate Research Center, University of Georgia, Athens, GA, United States.
Neil J GrimseyDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA, United States.
Lance WellsComplex Carbohydrate Research Center, University of Georgia, Athens, GA, United States.
Éric BergeronDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA, United States.
Scott D PeganDivision of Biomedical Sciences, University of California Riverside, Riverside, CA, United States.
University of Georgia · USCenters for Disease Control and Prevention · USUniversity of California, Riverside · US

Funding

Origin of the innate immunity suppression caused by nairovirus' protease activityR01AI151006 · NIAID · UNIVERSITY OF GEORGIA · PI PEGAN, SCOTT DUSAN · 2020 to 2024
$2.1M
Training Program for Antiretroviral Discovery, Evaluation and Application Research (ADEAR)T32AI150547 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Joshua Adam Barocas, Kristine Mace Erlandson · 2020 to 2026
$1.3M
NIAID NIH HHS R01 AI151006NIAID NIH HHS T32 AI150547
6 · The paper itself

Abstract

Post-translational modification of host and viral proteins by ubiquitin and ubiquitin-like proteins plays a key role in a host's ability to mount an effective immune response. Avian species lack a ubiquitin-like protein found in mammals and other non-avian reptiles; interferon stimulated gene product 15 (ISG15). ISG15 serves as a messenger molecule and can be conjugated to both host and viral proteins leading them to be stabilized, degraded, or sequestered. Structurally, ISG15 is comprised of a tandem ubiquitin-like domain (Ubl), which serves as the motif for post-translational modification. The 2'-5' oligoadenylate synthetase-like proteins (OASL) also encode two Ubl domains in series near its C-terminus which binds OASL to retinoic acid inducible gene-I (RIG-I). This protein-protein interaction increases the sensitivity of RIG-I and results in an enhanced production of type 1 interferons and a robust immune response. Unlike human and other mammalian OASL homologues, avian OASLs terminate their tandem Ubl domains with the same LRLRGG motif found in ubiquitin and ISG15, a motif required for their conjugation to proteins. Chickens, however, lack RIG-I, raising the question of structural and functional characteristics of chicken OASL (chOASL). By investigating chOASL, the evolutionary history of viruses with deubiquitinases can be explored and drivers of species specificity for these viruses may be uncovered. Here we show that the chOASL tandem Ubl domains shares structural characteristics with mammalian ISG15, and that chOASL can oligomerize and conjugate to itself. In addition, the ISG15-like features of avian OASLs and how they impact interactions with viral deubiquitinases and deISGylases are explored.

Indexed as

ImmunomodulationProtein Interaction Domains and Motifs2',5'-Oligoadenylate SynthetaseAmino Acid SequenceAnimalsCell LineChickensHumansMass SpectrometryModels, BiologicalProtein BindingProtein ConformationProtein Processing, Post-TranslationalProteolysisStructure-Activity RelationshipUbiquitin2',5'-Oligoadenylate SynthetaseUbiquitinViral Proteinsavian immunityISG15NairovirusOASLproteaseubiquitinUBL

Identifiers

PMID35058932
PMCPMC8764230
OpenAlexW4206691851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.